Captrust Financial Advisors Vanda Pharmaceuticals Inc. Transaction History

Captrust Financial Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.38 - $4.58 $47,127 - $63,858	13,943 New	13,943 $58,000
Q2 2022 Aug 16, 2022	SELL	$9.31 - $11.84 $4,999 - $6,358	-537 Reduced 32.21%	1,130 $12,000
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $1,875 - $2,863	-173 Reduced 9.4%	1,667 $19,000
Q4 2021 Feb 14, 2022	BUY	$15.69 - $21.14 $3,514 - $4,735	224 Added 13.86%	1,840 $29,000
Q3 2021 Nov 16, 2021	BUY	$15.35 - $21.27 $245 - $340	16 Added 1.0%	1,616 $28,000
Q1 2021 May 17, 2021	BUY	$13.42 - $20.28 $20,062 - $30,318	1,495 Added 1423.81%	1,600 $24,000
Q4 2020 Feb 16, 2021	BUY	$9.77 - $13.81 $537 - $759	55 Added 110.0%	105 $1,000
Q3 2020 Nov 17, 2020	BUY	$9.32 - $12.02 $466 - $601	50 New	50 $0

157

44.9M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.